Cosmetic Surgery Products

Published by: Freedonia Group Inc

Published: Dec. 1, 2010 - 283 Pages


Table of Contents

INTRODUCTION

I. EXECUTIVE SUMMARY

II. MARKET ENVIRONMENT

General

Macroeconomic Outlook

Demographic Trends

Consumer Spending Outlook

Physicians & Facility Trends

Spa Industry Outlook

Competitive Product Trends

Medical Product Market Outlook

Regulatory Issues

International Activity

III. COSMETIC PROCEDURES

General

Surgical

Reshaping

Implants

Breast Implants

Other Implants

Lifts & Tucks

Tummy Tucks

Facelifts

Breast Lifts

Forehead Lifts

Other Lifts

Liposuction

Other Surgical

Nonsurgical

Injections

Botulinum Toxin

Soft Tissue Fillers

Other Injections

Dermal Resurfacing

Laser Treatments

Laser Hair Removal

Laser Dermal Resurfacing

Other Laser Treatments

Other Nonsurgical

IV. PRODUCTS

General

Injectables

Botulinum Toxin

Soft Tissue Fillers

Hyaluronic Acid

Collagen

Other Soft Tissue Fillers

Other Injectables

Equipment

Lasers

Hair Removal Lasers

Dermal Resurfacing Lasers

Other Lasers & Light-Based Systems

Microdermabrators

Liposuction Equipment

Other Equipment

Consumables

Implants

Breast Implants

Other Implants

Lip Implants

Chin & Cheek Implants

All Other Implants

Wound Care Disposables

Bandages & Dressings

Wound Closures

Other Wound Care Disposables

Other Cosmetic Surgery Products

V. RAW MATERIALS

General

Biological Materials

Microbial Extracts

Collagen

Other Biological Materials

Polymers

Other Raw Materials

VI. INDUSTRY STRUCTURE

General

Market Share

Industry Restructuring

Competitive Strategies

Research & Development

Cooperative Agreements

Marketing

Company Profiles

Aesthera, see Solta Medical

Alcon Incorporated

Allergan Incorporated

Alma Lasers Limited

BioForm Medical, see Merz

Candela, see Syneron Medical

Covidien plc

Cutera Incorporated

Cynosure Incorporated

Dectro International

DermaMed USA Incorporated

Diamond International Corporation Pty Limited

Dynatronics Corporation

Ethicon, see Johnson & Johnson

ExcellaDerm Corporation

Genesis Biosystems Incorporated

Genzyme Corporation

Hoya Corporation

Implantech Associates Incorporated

IRIDEX Corporation

Johnson & Johnson

Kendall, see Covidien

Kinetic Concepts Incorporated

LifeCell, see Kinetic Concepts

Lumenis Limited

Med-Aesthetic Solutions Incorporated

Medicis Pharmaceutical Corporation

Mentor Worldwide, see Johnson & Johnson

Merz GmbH & Company KGaA

Palomar Medical Technologies Incorporated

Q-Med AB

Sanofi-Aventis

Smith & Nephew plc

Solstice Neurosciences Incorporated

Solta Medical Incorporated

Suneva Medical Incorporated

Syneron Medical Limited

Syneture, see Covidien

3M Company

Other Companies Mentioned in Study

LIST OF TABLES

SECTION I -- EXECUTIVE SUMMARY

Summary Table

SECTION II -- MARKET ENVIRONMENT

1 Macroeconomic Indicators

2 Population & Households

3 Personal Consumption Expenditures

4 Physicians & Facilities

5 Spa Facilities by Type

6 Medical Product & Equipment Demand

SECTION III -- COSMETIC PROCEDURES

1 Cosmetic Procedures Demand by Type

2 Surgical Cosmetic Procedures Demand by Type

3 Cosmetic Reshaping Procedures Demand by Type

4 Cosmetic Implant Procedures Demand by Type

5 Cosmetic Lift & Tuck Procedures Demand by Type

6 Liposuction Procedures Demand by Type

7 Other Surgical Cosmetic Procedures Demand by Type

8 Nonsurgical Cosmetic Procedures Demand by Type

9 Cosmetic Injections Demand by Type

10 Cosmetic Botulinum Toxin Injections Demand

11 Cosmetic Soft Tissue Filler Injections Demand by Type

12 Other Cosmetic Injections Demand by Type

13 Cosmetic Dermal Resurfacing Treatment Demand by Type

14 Cosmetic Laser Treatment Demand by Type

15 Other Nonsurgical Cosmetic Procedures Demand

SECTION IV -- PRODUCTS

1 Cosmetic Surgery Product Demand by Type

2 Cosmetic Injectables Demand by Type

3 Cosmetic Botulinum Toxin Demand by Formulation

4 Cosmetic Soft Tissue Filler Demand by Type

5 Cosmetic Hyaluronic Acid Filler Demand by Formulation

6 Cosmetic Collagen Filler Demand by Formulation

7 Other Cosmetic Soft Tissue Filler Demand by Type

8 Other Cosmetic Injectables Demand by Type

9 Cosmetic Surgery Equipment Demand by Type

10 Cosmetic Laser Demand by Procedure

11 Microdermabrator Demand

12 Liposuction Equipment Demand

13 Other Cosmetic Surgery Equipment Demand by Type

14 Cosmetic Surgery Consumables Demand

15 Cosmetic Implant Demand by Type

16 Cosmetic Breast Implant Demand by Type

17 Other Cosmetic Implant Demand by Type

18 Wound Care Disposables Demand in Cosmetic Surgery by Type

19 Bandages & Dressings Demand in Cosmetic Surgery

20 Wound Closures Demand in Cosmetic Surgery by Type

21 Other Wound Care Disposables Demand in Cosmetic Surgery

22 Other Cosmetic Surgery Product Demand

SECTION V -- RAW MATERIALS

1 Raw Materials Demand in Cosmetic Surgery Products by Type

2 Biological Materials Demand in Cosmetic Surgery Products

3 Polymers Demand in Cosmetic Surgery Products

4 Other Raw Materials Demand in Cosmetic Surgery Products

SECTION VI -- INDUSTRY STRUCTURE

1 US Cosmetic Surgery Product Sales by Company, 2009

2 Selected Acquisitions & Divestitures

3 Selected Cooperative Agreements

LIST OF CHARTS

SECTION II -- MARKET ENVIRONMENT

1 World Cosmetic Surgery Product Demand, 2009

SECTION III -- COSMETIC PROCEDURES

1 Cosmetic Procedures Demand by Type, 1999-2019

2 Surgical Cosmetic Procedures Demand by Type, 2009

3 Nonsurgical Cosmetic Procedures Demand by Type, 1999-2019

4 Cosmetic Soft Tissue Filler Injections Demand by Type, 1999-2019

SECTION IV -- PRODUCTS

1 Cosmetic Surgery Product Demand by Type, 1999-2019

SECTION VI -- INDUSTRY STRUCTURE

1 US Cosmetic Surgery Product Market Share by Company, 2009

Abstract

US demand to grow 6.5% annually through 2014
Demand for products used in cosmeticsurgery is forecast to increase 6.5 percentper year to $2.8 billion in 2014, when16.1 million cosmetic procedures areexpected to be performed. The economicrecession that began in December 2007impacted the cosmetic surgery industrymost profoundly in surgical procedures,which suffered large drops in 2008 and2009. Likewise, demand for equipmentused to perform these surgeries fell moresharply than did that for less expensive,non-invasive nonsurgical procedures.Busy lifestyles and pervasive unemploymentrates have led to rapid increases indemand for minimally invasive procedures(such as injections and laser-basedprocedures). Minimally or non-invasiveprocedures will continue to take marketshare from invasive surgeries, althoughhealthy growth will remain in some areas,such as implants, where there are nonotable alternatives.

Lasers, other light-based equipment to remain largest, fastest-growing
Equipment has traditionally held thelargest share of the cosmetic surgeryproduct market, and in 2009 accountedfor over one-third of demand. Purchasesof equipment were slowed by therecession and should see a strongrebound. Lasers and other light-basedsystems will continue to be the largestsector of equipment demand, and will seethe fastest growth going forward as newlaser-based treatments such as noninvasiveliposuction enter the market.

Injectables and implants fastest-growing products
Through 2014, injectables and implantswill continue to be the two fastestgrowingproduct segments. Growth indemand for injectables has boomed sincethe 1990s when BOTOX (Allergan) firstentered the market. Cosmetic injectionsbenefit from increasing societal acceptanceas well as high consumer awarenessof their ability to provide a quick, noninvasivereduction in wrinkles with norecovery time. With 2009 and 2010market approvals of competing botulinumtoxin-based injectables, BOTOX isseeing its first direct competition, whichis expected to have significant impact onthe market. Development of newergenerationsoft tissue fillers will alsocontinue, with this segment expected tosee the fastest gains among injectables.Implants will continue to benefit fromsilicone’s market re-entry in 2006, asbreast implants -- the most commonaesthetic surgical procedure -- remainfast-growing. Next-generation implantmaterials (so-called “gummy bear”implants) are forecast to enter the marketonce they receive FDA approval followingclinical testing. These higher-valueimplants will drive further value gains.

Please Note: Freedonia requires that, for PDF orders, clients sign a confidentiality agreement prior to fulfillment of PDF email delivery.

Get full details about this report >>
 
Learn more about this product


Price and delivery options

See related reports or call the number below for help from a research specialist.

US: 800.298.5699

Int'l: +1.240.747.3093


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 720 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.